NICE recommendations for drug coverage shown to have little impact

05/26/2004 | Financial Times (free content)

Pharmaceutical industry and related studies indicate the U.K.'s National Institute for Clinical Excellence, which recommends to the National Health Service which drugs to cover, has little impact on the introduction of new treatments. If the NICE recommendations had been adopted, according to studies by Roche, NICE and the Association of British Pharmaceutical Industry, they would have added millions to NHS drug coverage costs.

View Full Article in:

Financial Times (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC